Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
1,4-Dicaffeoylquinic acid is a polyphenol that has been found in C. coronarium and has diverse biological activities.1,2,3,4 It scavenges DPPH (Item No. 14805) radicals and inhibits xanthine oxidase (XO; IC50 = 7.36 µM).1,2 1,4-Dicaffeoylquinic acid (25 µM) decreases protein levels of tyrosinase and microphthalmia-associated transcription factor (MITF) in B16/F1 murine melanocytes, inhibits melanogenesis in the same cells, and decreases tyrosinase activity in B16/F1 cell lysates.3 It increases biliary flow in rats in a dose-dependent manner.4
WARNING This product is not for human or veterinary use.
1. Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology 62(2), 1152-1161 (2012).
2. Insights from multispectral and molecular docking investigation on the xanthine oxidase inhibition by 1,4-
3. Mechanism underlying inhibitory effect of six dicaffeoylquinic acid isomers on melanogenesis and the computational molecular modeling studies. Bioorg. Med. Chem. 26(14), 4201-4208 (2018).
4. Comparison of choleretic effects of CYN and Na-